Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.57p
   
  • Change Today:
      0.010p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 778,494
  • Market Cap: £12.84m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £38,254
Lisa Baderoon 583,963 £15,008
Tim Franklin 525,000 £13,492

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 80,590,404 £2,071,173
Luca & Associates AG 22,000,000 £565,400
Invesco Ltd 17,872,341 £459,319
Aviva Investors Global 11,285,180 £290,029
Alora Pharmaceuticals LLC 10,909,091 £280,364
M&G Investments 7,600,000 £195,320
Prudential plc 7,600,000 £195,320
Capital Income Builder 4,870,367 £125,168
Dr R Zimmer 4,551,553 £116,975
Odey Asset Management 3,433,319 £88,236
Rhone Trustees (Switzerland) SA 3,386,000 £87,020
Pictet Overseas Trust Corporation Limited 3,287,500 £84,489

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.57p
Change Today 0.010p
% Change 0.39 %
52 Week High 5.90
52 Week Low 1.09
Volume 778,494
Shares Issued 499.72m
Market Cap £12.84m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.19% below the market average73.19% below the market average73.19% below the market average73.19% below the market average73.19% below the market average
36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average
Price Trend
81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
15:33 61,799 @ 2.40p
15:33 61,799 @ 2.40p
15:26 196,293 @ 2.39p
15:01 60,000 @ 2.35p
14:06 19,940 @ 2.46p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page